Mirum Pharmaceuticals, Inc.
Clinical trials sponsored by Mirum Pharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug could soothe unbearable itch in rare liver conditions Results expected Oct 2026 (estimated)
- New pill aims to stop the relentless itch of a rare liver disease Results expected Jan 2027 (estimated)
- New hope for hepatitis delta: phase 3 trial launches Results expected Jun 2027 (estimated)
- New hope for hepatitis delta: can switching drugs clear the virus? Results expected Aug 2027 (estimated)